[Determination of plasma hemoglobin in fresh plasma for therapeutic use by the TMB (3,3',5,5'-tetramethylbenzidine) method].
The maximum level of plasma hemoglobin in standard fresh frozen plasma before freezing has been mixed at 50 mg/l by french regulations. As no reference method is specified by the standards, we have adapted a technique where pseudo-peroxydasic activity of the hemoglobin is revealed by 3,3'-5,5', tetramethylbenzidine, a non carcinogenic chromogen derivate from benzidine. A 4 points reference scale is plotted for each plasma to be tested, thus reducing eventual interferences between pseudo-peroxydasic activity of the hemoglobin and other plasma proteins. We compared our modified technique to other existing ones: Vanzetti's extraction technique [8] whose main drawbacks are the use of flammable solvents and carcinogenic chromogen. Standefer's technique [10] involving plasma preincubation in H2O2 solution, which reveals protein interferences but is imprecise as it relies on only one reference point and does not show whether chromogen saturation is present. The level fixed by regulations is higher than the mean level indicated by our method, based on 118 samples of fresh plasma obtained by double centrifugation of whole blood collected on CPD as anticoagulant. It is also higher than the level indicated by the same method for plasma samples drawn from continuous or discontinuous flow cytapheresis (IBM 2997; Haemonetics V 50) using ACD - A or ACD - AA 16 as anticoagulant. Our method measures with precision low levels in plasma. Furthermore it is cheap, simple and easy to run in a blood transfusion center.
D001560:Benzidines; D001798:Blood Proteins / Q000378:metabolism; D001803:Blood Transfusion; D006454:Hemoglobins / Q000032:analysis*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D010949:Plasma / Q000032:analysis*; D013053:Spectrophotometry
D001560:Benzidines; D001798:Blood Proteins; D006454:Hemoglobins; C021758:3,3',5,5'-tetramethylbenzidine
Dosage del'hémoglobine plasmatique dans les plasmas frais à utilisation thérapeutique par la méthode à la T.M.B. (3,3'-5,5 tétraméthylbenzidine).